chrisvoncsefalvay/vaers-outcomes huggingface dataset:
little light headed; couldn't take deep breaths/ started having winded feeling; had swollen lymph nodes under my left arm; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (little light headed), DYSPNOEA (couldn't take deep breaths/ started having winded feeling) and LYMPHADENOPATHY (had swollen lymph nodes under my left arm) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     Concurrent medical conditions included Asthmatic and Allergy (allergic to everything since childhood).    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (little light headed) and DYSPNOEA (couldn't take deep breaths/ started having winded feeling). an unknown date, the patient experienced LYMPHADENOPATHY (had swollen lymph nodes under my left arm). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, DIZZINESS (little light headed), DYSPNOEA (couldn't take deep breaths/ started having winded feeling) and LYMPHADENOPATHY (had swollen lymph nodes under my left arm) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Heart rate: rapid (High) rapid heartbeat, Intermittent episodes came back again on and off for 4 days.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.
55 year old Female Medical Assistant who has had yearly injectable flu vaccines for the past five years without prior adverse reactions. Her only medication is Thyroid Replacement. No significant past medical illness. 10/10/2012 Recheck of L.P. by MD. She continue to have no symptoms other than fullness in the left and right supraclavicular fossa. No pain. No swelling. Examination shows soft tissue fullness without lumps or nodules. The area is not warm, not tender and not lumpy. No neck nodes palpable. No Axillary nodes. ASSESSMENT: unusual soft tissue swelling in the supraclavicular areas bilaterally occuring s/p Tri Valent Flu shot. Swelling according to the patient is a little less. But by my eye there is not any substantial difference compared to one week ago. MD called State Health Department. Will send inquiry to CDC and file VAERS report. Patient brought to my attention from the flu crew. Patient had a flu shot on 9/26/2012 in the left deltoid. The patient noted that there was fullness and swelling two days later on Friday 9/28/2012. She has not had any redness swelling pain fevers or discomfort. She has had a flu shot yearly for the past five years. She denies shortness of breath or difficulty breathing. No weight loss. No hand pain or arm pain. No night sweats. 138/62, P 68, RR 12, Temp 98.8 Oral. Exam: Fullness in the left more than right supraclavicular area. No palpable nodes But has visible fullness. No nodular component. No axillary nodes. No nodes in the popliteal fossa. There is a contusion on the left deltoid from the flu shot. Arm has normal perfusion and sensation. Neck with full range of motion. Chest clear to A regular rate and rhythm no murmurs. No hepatospleenomegaly on abdomen exam. No leg edema No facial edema. 10/3/2012 Patient Instructions: You have fullness in the left more than right supraclavicular fossa. This does not appear to be lymph nodes. The soft tissue swelling is of unclear significance. Please follow up with MD one week from today on Wed 10/10/2012 at 8 AM in the office. Call me if you have fevers, redness of the site, worsening swelling or new symptoms. This may or may not be related to the flu shot. This would be a very unusual reaction to flu shots.
This spontaneous report was received from a Pharmacist concerning a patient of unknown age and gender. On 09-NOV-2012, the patient was vaccinated with the first dose of GARDASIL (dose, route and lot # not reported). On 18-NOV-2013, the patient was vaccinated with the second dose of GARDASIL (dose, route and lot # not reported. No adverse effects were reported. Patient's outcome was unknown. Additional information is not expected.
Mother states left arm (upper) became swollen from shoulder to just above elbow within 24 hours. Now resolved with only a hardened area at injection site of DTPa. Area very hot. Mother used Tylenol for comfort.
Body aches, headache, shivering, fever, vomiting, nose bleed, and nausea.
Report received from Plasma Center employee on 23-Oct-2008:  A 58 year-old female received AFLURIA (CSL Influenza vaccine) IM at left deltoid on 20-Oct-2008 at 9:53 AM (0953).  AFLURIA lot # administered 03549111A, exp date 30-JUN-2009.  The patient had no illnesses at the time of vaccination.  Concomitant medications reported as hydrocodone prn and OTC allergy medication prn.  Reporter indicates the patient has experienced adverse events following prior vaccinations: at age 20 (??-???-1970) with cholera vaccination and at age 31 (??-???-1981) with swine flu vaccination.  On 21-Oct-2008, at 10:00 AM, approximately 24 hours post-vaccination, the patient complained of nausea, muscle pain, malaise and vomited once.  The reporter indicates the patient was recovered at the time of the report (23-Oct-2008).  The reporter considered the event as non-serious.  No further information is expected.  No serious criteria mentioned.  Causality:  Possible.  Follow-up information received on 28-Oct-2008 from Plasma Center Employee.  The patient did not contact her primary care physician, she is not pregnant, and she recovered fully.  No further information is expected.  Information derived from this report does not change the current safety profile of the product.
patient was anxious before the vaccination.  after vaccination, he wanted walk around then sit.  he sat on the floor and was stating that he had a phobia to needles/shots.  he passed out briefly and came to shortly afterwards.  911 called, very low bp.  patient and wife were moved to ambulance where patient eventually felt better and was able to walk.  patient and wife did not want to go to hospital.  we called him later to check on patient, he said he was feeling much better.
Pt. called to report that after receiving H1N1 vaccine yesterday 1-14-2010 she developed/experienced a tachycardia episode but denied any other sx including dyspnea, diophoresis chest pain or other related sx. Feels well today just some fatigued sx. LPN.
Patient got the first dose somewhere else and came to us for 2nd dose. He stated it was time for his 2nd dose. He didn't the vaccine card with him. We gave the shot and advised him to return to the first location to get the card. He came back later with the card and we found out that he wasn't due for the 2nd one yet (7 days earlier).
Spot where I had the shot is very swollen and red; Spot where I had the shot is very swollen and red; This is a spontaneous report from a contactable consumer or other non hcp. A patient of unspecified age and gender received BNT162B2, (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection Lot Number: FA7484), via an unspecified route of administration on an unspecified date, dose number unknown, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. It was reported that the patient had the vaccine on Saturday. The patient reported that the spot where he/she had the shot was very swollen and red but noticed it was magnetic. The patient put a quarter or penny or whatever on that spot it stays there until he/she removed it. The patient was asking what was magnetic in that shot. The clinical outcome for events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
I can not think or remember things my arms go to sleep i cant feel hot and cold i cant drive and i get very winded
MMR recvd in lt thigh w/an immediate reddened are w/hives around inject site;
Started to feel very tired, and unexplained bruising on thighs and buttock. Blood pressure went high and heart rate as well. Caught Molluscum contagiosum a week later as well. Almost two months later still dealing with weird side effects. In the past week broke out in a rash all over body which was biopsied and came back as a allergic reaction.
Patient reports swelling from left bicep up into the top of left shoulder. Denies any other sympoms
Pt sweaty; local heat and cold. Per a telephone call to clinic on 6/22/01, pt developed the following symptoms. "Even slight movement of the right forearm or hand causes intense pain in the elbow and wrist. No red streaks, no fever and no history of arthritis. Dx reflex sympathetic dystrophy RUE. Treatment with Prednisone 30mg po bid X 5 days, then 1 tablet in AM and 1/2 tablet in PM X 5 days. Use Tylenol. Occupation therapy evaluation 1 X weekly. Cold packs prn.
Patient present to ED after a fall in his bathroom. Had congestion/fatigue for 2 days prior to this. Wife has also been ill.
Severe chills, shaking, painful white fingers and toes, joints, headache, muscle aches for 2 days.
Headache, Myalgia, Arthralgia, NauseaVomiting, Fatigue, chills Narrative:
About 6 Days later noticed tinnitus in both ears. It may have come a little earlier.  It has not gone away since the 1st shot. Very annoying.
No additional AE; Caller reported one year old received PROQUAD and VARIVAX at same office visit.  No other information provided.  No additional AEs or PQC reported.; proquad given instead of mmr; This spontaneous report was received from a nurse and other Health Professional (also reported as a vaccine coordinator) and refers to a 12-month-old female patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported.  On 03-JUL-2023, the patient was vaccinated with a dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) at 0.5ml, in the right tight , subcutaneously which had a lot # W036938 with expiry date on 19-MAY-2024, instead of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II). However, the patient received an additional dose with varicella virus vaccine live (oka/merck) (VARIVAX) in left arm, subcutaneously, lot # W031813 expiration date on 05-OCT-2024 (Contraindicated product administered) (Wrong product administered). The Medical assistant inadvertently gave of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) and did not realize it until after administration. The patient was also vaccinated with hepatitis a vaccine, inactivated (VAQTA) , lot #X004814, expiration date: 10-OCT-2024, administered intramuscularly for prophylaxis (strength was not provided); intramuscular, the fourth dose of pneumococcal 15v conj vaccine (crm197) (VAXNEUVANCE) and the third dose of hib vaccine conj (tet tox) (ACT HIB) in the right tight intramuscularly.   The physician immediately notified and tried to call the family to check on the patient. However at the reporting time, no adverse events were reported.
Patient reports getting her 2nd vaccine near 3PM and that evening had symptoms including high fever and paralysis.  Paralysis lasted until 9am and patient reports symptoms including rigors, fever, pain and lethargy lasting about 3 days with the symptom of lethargy continuing.  VEARS reporting information given to client who is a nurse and she states she will self report.
Initial unsolicited report received from a consumer on 21 April 2015. A female patient, whose medical history and concomitant medications were not reported, had received a dose of INFLUENZA VACCINE (batch number, expiry date, dose, dose number, route and site of administration were not reported) on an unspecified date. On an unspecified date, many years ago after vaccination, patient was sick and had vomiting. Laboratory investigations and corrective treatment were not reported. At the time of this report, outcome of the event was unknown. Documents held by sender: none.
Patient developed 10 vesicular rash scattered on his chest, neck, back & scalp on 6/19/09
1/31/22 at 5:00 pm - Left arm is red, swollen and hot to the touch.  2/1/22 at 7:00 am - Arm still red, swollen, and warm. Also has fever, decreased appetite, and feels ?dizzy. ?
Golf ball sized lump developed at injection site about 24 hours/Lump is raised about 1 cm and itchy; Golf ball sized lump developed at injection site about 24 hours/Lump is raised about 1 cm and itchy; This is a spontaneous report from a contactable consumer. This 33-year-old male consumer (Patient) reported that.  A 33-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: Ew0162), dose 1 via an unspecified route of administration, administered in Arm Left on 17Apr2021 12:30 as (At the age of 33-years) dose 1, single for covid-19 immunisation. Nonmedical history was not reported. There were no concomitant medications. No other vaccine in four weeks. No Other medications in two weeks. No COVID prior vaccination. No COVID tested post vaccination. No Known allergies ware reported. On 18Apr2021 12:30 patient experienced Golf ball sized lump developed at injection site about 24 hours. Lump is raised about 1 cm and itchy. Has been present for 10 days and counting. Patient was not received any treatment for events. The outcome events was not recovered at the time of report.    No follow-up attempts are possible. No further information is expected.
Today developed Temp: 101 went up to 101.8;  Taken motrin.
RN gave injection x2 to right thigh and patient initially held breath for 2 seconds while crying then appeared to have approx. 3-5 seconds seizure-like activity then back to baseline activity (ie. crying). Vital signs stable patient crying. Mother reports patient has never had a seizure however Mother has hx of seizures.  Nurse practitioner evaulated patient and recommended to take pt. to ER/PCP for for further follow-up.  No other vaccines given.
Immediately following my vaccination and in the seventeen months since, I have perspired from my head very profusely. I had never been especially sweaty, but I sweat very easily, very heavily from my head since receiving the J&J single shot COVID-19 vaccine.
This spontaneous report was received from a health professional refers to unknown number of unspecified patients of unknown gender and age. Information regarding patients' medical history, current conditions, drug reactions/allergies and concomitant medications were not provided. On an unknown dates, the patients were vaccinated with improperly stored doses of VAQTA (lot # K012457, expiry date: 04-JUN-2017). No adverse effect was reported. This is one of the three reports received from the same reporter. Additional information has been requested.
no adverse event; improperly stored vacine in use; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. Information about patient's concurrent condition, concomitant medication, medical history, drug allergy/reaction was not reported.  On 04-MAR-2020, the patient was vaccinated with a dose of improperly stored rotavirus vaccine, live, oral, pentavalent(ROTATEQ) lot # 1660942, expiry date: 06-FEB-2021 for prophylaxis (strength, dose number, anatomical location, route was not reported) (product storage error). It was reported that the vaccine was exposed to a multiple temperature excursion of below 2 degree Celsius (1.28 C) for a time frame of 2 hours and 30 hours. There was no previous temperature excursion reported. Data logger was involved. No adverse events reported. No product quality complaint was involved.
fever; fatigue; This is a spontaneous report from a contactable consumer (patient) or other non-healthcare professional received via mail.  A 69-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID -19 VACCINE, solution for injection, Lot Number: EW0180, Expiry date: not reported) via an intramuscular route of administration, administered in right arm (upper) on 04Jun2021 at 11:20 as dose 2, single for COVID-19 immunization. Medical history included ongoing stage 3 kidney disease (likely secondary to ileostomy), ongoing arthritis (knees, elbows, shoulders and ankles), ongoing ileostomy from Jan2012 (following surgery to treat small bowel obstruction), urinary tract disorder and pain. Concomitant medications included buprenorphine (BUTRANS), transdermal from unknown date to ongoing at unknown dose and frequency for pain; tamsulosin hydrochloride (FLOMAX [TAMSULOSIN HYDROCHLORIDE]), orally from unknown date to ongoing at unknown dose and frequency for urinary tract; finasteride, orally from unknown date to ongoing at unknown dose and frequency for urinary tract. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID -19 VACCINE, solution for injection, Lot Number: EW0182, Expiry date: not reported) via intramuscular route of administration, administered in right arm (upper) on 04May2021 at 11:20 as dose 1, single for COVID-19 immunization and on 17 May2021, the patient experienced joint pain (experienced severe pain in right knee and left shoulder starting 3 days after 1st vaccination. Pain in knee quite intense. Resolved after 5-7 days). On an unspecified date in 2021, the patient experienced fever and fatigue. Patient reported that after second vaccine had no joint issues. Patient experienced fever (100.8 F) and fatigue for 1-2 days. On an unspecified date in 2021, the patient underwent lab tests which included body temperature: 100.8 fahrenheit. The clinical outcome of the events were resolved on an unspecified date in 2021. No follow-up attempts are needed. Information about batch number cannot be obtained.
Chills and moderate to severe fatigue throughout the day of 04/07/2021; headache throughout the day escalating into a migraine at night (began at roughly 9:00 pm) that persisted through most of the night
Large bilateral pulmonary emboli and left lower extremity DVT diagnosed a few days after Modern booster
her face had turned bright red; She began itching; She is not sure if it was welts or what, but it was like a rash pretty much all over her body, not just at the injection site; Rash all over her body; Headache; Aches; Sleepy; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 48 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 07Dec2021 11:15 (Lot number: FJ8762) at the age of 47 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Verbatim: Type I Diabetes", start date: 1980 (ongoing), notes: Verbatim: Type I Diabetes; "allergic reaction to penicillin" (unspecified if ongoing), notes: In the past, she has had an allergic reaction to penicillin and latex.; "allergic reaction to penicillin and latex." (unspecified if ongoing), notes: In the past, she has had an allergic reaction to penicillin and latex. Concomitant medication(s) included: INSULIN SHOT taken for type 1 diabetes mellitus. Vaccination history included: Bnt162b2 (dose 1, Lot no./ Expiry Date: EN6202/ Unknown, left arm), administration date: 08Mar2021, when the patient was 47 years old, for COVID-19 immunization; Bnt162b2 (dose 2, Lot no/ Expiry Date: Unknown, thinks it was in her Left arm), administration date: 29Mar2021, when the patient was 48 years old, for COVID-19 immunization; Flu shot (had a flu shot a month before), for Immunization. The following information was reported: RASH (non-serious) with onset 07Dec2021, outcome "recovering", described as "Rash all over her body"; HEADACHE (non-serious) with onset 07Dec2021, outcome "not recovered", described as "Headache"; PAIN (non-serious) with onset 07Dec2021, outcome "not recovered", described as "Aches"; SOMNOLENCE (non-serious) with onset 07Dec2021, outcome "not recovered", described as "Sleepy"; ERYTHEMA (non-serious), outcome "unknown", described as "her face had turned bright red"; PRURITUS (non-serious), outcome "unknown", described as "She began itching"; URTICARIA (non-serious), outcome "unknown", described as "She is not sure if it was welts or what, but it was like a rash pretty much all over her body, not just at the injection site".  No follow-up attempts are possible. No further information is expected.
Fever 102.6. Fever lasted 36 hours with a downward trend Achy lasted 2 days Headache lasted 2 days Nausea lasted 2 days Chills lasted 36 hours Site pain level 8 lasted one week with less pain each day Fatigue lasted 36 hours Tiredness lasted 36 hours Dizziness- lasted 5 days  All adverse reactions have resolved
Seen on 3/13/09 for 10 year old well child visit.  Recieved varivax #2.  On 3/15/09 developed large area of redness, pai, and warmth on left arm.  Seen in our office and diagnosed with LUE cellulitis secondary to vaccination.  Treated with Augmentin.
Pt had a varivax vac given on 09/05/1997. Pt was Dx with Varicella on 08/29/2002.
Patient had injection. Several minutes later patient's eyes rolled up in his head and he started having seizure/jerking like movements that lasted approximately 3-4 minutes. Sent to ED for evaluation.
Moderna Covid-19 Vaccine EUA  Extreme pain and swelling in the right shoulder joint the evening  of the injection and tingling, numbness in hand.  Unable to raise my arm. Extreme pain and swelling continued for several days.  Pain began to subside and now able to move my arm but still have dull ache in  joint and pain when arm is raised in certain directions. The injection site was very high on my arm and close to the joint.  The day after the injection I had headache, nausea, chills, dizziness, fatigue. This lasted until the evening and by the second day was better. Still fatigued for several days.
Tinnitus; Occasional ringing; Arm is really hurting; Hearing a hissing sound in my ears; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), on 18Nov2021 as dose 3 (booster), single (Lot number: FH8028) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: BNT162b2 (Dose 1), administration date: 21Mar2021, for COVID-19 Immunization; BNT162b2 (Dose 2, And it started from a pain in my arm and a little bit of fatigue.), administration date: 28Mar2022, for COVID-19 immunization, reaction(s): "pain in my arm", "little bit of fatigue". The following information was reported: TINNITUS (non-serious) with onset Nov2021, outcome "unknown", described as "Hearing a hissing sound in my ears"; PAIN IN EXTREMITY (non-serious) with onset 18Nov2021, outcome "unknown", described as "Arm is really hurting"; TINNITUS (non-serious), outcome "unknown"; TINNITUS (non-serious), outcome "unknown", described as "Occasional ringing".  No follow-up attempts are possible. No further information is expected.
No additional AE was reported; Gardasil 9 was exposed to a the temperature excursion and was administered to a patient; This spontaneous report has been received from a nurse referring to a 12 year old female patient. Information regarding the patient's medical history, drug reactions or allergies, concurrent conditions and concomitant medications was not provided.      On 19-OCT-2020, the patient was vaccinated with an improperly stored dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) lot # 1614898 with expiration date of 15-NOV-2021 (strength, dose, route, frequency, anatomical location, lot # and expiration date were not provided) for prophylaxis. The vaccine was exposed to a temperature of 13 °C during 30 minutes which was called by a data logger.
7 days after receiving Anthrax and MGC vaccination and 1 day after receiving the Smallpox vaccination, Patient developed right sided facial numbness with very slight weakness--this eventually spread to entire face.  No overt motor symptoms or physical findings.